3 PAREXEL International Corp. Analyst Ratings, Earnings, Dividends and Insider Trades | $PRXL | NASDAQ:PRXL | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact PAREXEL International Corp. Company Profile (NASDAQ:PRXL) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for PAREXEL International Corp. (NASDAQ:PRXL) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 5 Buy Rating(s), 2 Strong Buy Rating(s)Consensus Rating:Buy (Score: 2.57)Consensus Price Target: $52.38 5.27% downside) Analysts' Ratings History for PAREXEL International Corp. (NASDAQ:PRXL) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/18/2014Citigroup Inc.Initiated CoverageBuyView 1/30/2014BarclaysBoost Price TargetOverweight$48.00 -> $52.00View 1/22/2014ISI GroupUpgradeBuy -> Strong-Buy$53.00 -> $56.00View 12/23/2013Ned Davis ResearchUpgradeNeutral -> BuyView 11/20/2013Deutsche BankInitiated CoverageHold$50.00View 10/30/2013William BlairDowngradeOutperform -> Market PerformView 10/25/2013Robert W. BairdDowngradeOutperform -> NeutralView 10/7/2013Sterne AgeeReiterated RatingUnderperform$36.00 -> $51.07View 10/4/2013ISI GroupUpgradeNeutral -> Buy$52.50 -> $57.00View 9/30/2013Ned Davis ResearchDowngradeBuy -> NeutralView 9/23/2013Credit SuisseInitiated CoverageOutperformView 9/17/2013UBS AGInitiated CoverageBuy$58.00View 9/9/2013ZacksDowngradeOutperform -> Neutral$55.00View 8/14/2013Sterne AgeeDowngradeNeutral -> Underperform$44.00 -> $36.00View 8/8/2013Jefferies GroupReiterated RatingHold$46.00 -> $47.00View 7/26/2013ZacksUpgradeNeutral -> Outperform$53.00View 7/1/2013Raymond JamesUpgradeMarket Perform -> Strong-BuyView 6/27/2013ZacksDowngradeOutperform -> Neutral$51.00View 6/27/2013Jefferies GroupReiterated RatingHold$41.00 -> $43.00View 6/11/2013Sterne AgeeInitiated CoverageNeutral$44.00View 5/21/2013International Strategy & InvestmentInitiated CoverageNeutral$50.00View 5/21/2013ISI GroupInitiated CoverageNeutralView 5/1/2013Jefferies GroupBoost Price TargetHold$36.00 -> $41.00View 3/25/2013Citigroup Inc.Boost Price TargetBuy$36.00 -> $45.00View 3/12/2013Jefferies GroupBoost Price TargetHold$31.00 -> $36.00View 1/30/2013Jefferies GroupReiterated RatingHold$31.00View 1/30/2013Robert W. BairdReiterated RatingOutperform$42.00 -> $37.00View 1/16/2013Robert W. BairdReiterated RatingOutperform$37.00 -> $34.00View 1/14/2013Sterne AgeeReiterated RatingUnderperform$23.50 -> $27.00View 1/14/2013Goldman SachsUpgradeSell -> Neutral$28.00 -> $36.00View 1/2/2013Citigroup Inc.UpgradeNeutral -> Buy$34.00 -> $36.00View 12/27/2012Jefferies GroupReiterated RatingHoldView 12/27/2012Sterne AgeeReiterated RatingUnderperformView 11/1/2012Raymond JamesDowngradeOutperform -> Market PerformView 10/5/2012Jefferies GroupDowngradeBuy -> Hold$31.50 -> $31.00View 9/25/2012Citigroup Inc.Boost Price Target$34.00View 5/2/2012Jefferies GroupLower Price TargetBuy$32.50 -> $31.50View 4/19/2012Wells Fargo & Co.UpgradeMarket Perform -> OutperformView 4/2/2012Sterne AgeeDowngradeNeutral -> Underperform$24.50View 3/28/2012Citigroup Inc.UpgradeBuyView 3/28/2012Jefferies GroupUpgradeHold -> Buy$22.00 -> $32.50View 3/22/2012Raymond JamesUpgradeMarket Perform -> OutperformView (Data available from 3/7/2012 forward) Earnings History for PAREXEL International Corp. (NASDAQ:PRXL)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare1/30/2014Q214$0.49$0.49$479.49 million$487.10 millionViewListenView 10/30/2013Q114$0.45$0.45$458.94 million$449.20 millionViewListenView 8/7/2013Q4 2013$0.43$0.50$455.23 million$463.10 millionViewListenView 4/30/2013Q3 2013$0.40$0.50$438.10 million$454.49 millionViewListenView 1/29/2013Q2 2013$0.33$0.41$419.78 million$422.10 millionViewListenView 10/30/2012Q113$0.29$0.29$396.70 million$394.80 millionViewN/AView 4/30/2012$0.31$0.33ViewN/AView 1/30/2012$0.23$0.23ViewN/AView 10/31/2011$0.15$0.20ViewN/AView 8/9/2011$0.07$0.10ViewN/AView 5/2/2011$0.30$0.27ViewN/AView 1/31/2011$0.28$0.28ViewN/AView (Data available from 1/1/2011 forward) Dividend History for PAREXEL International Corp. (NASDAQ:PRXL)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for PAREXEL International Corp. (NASDAQ:PRXL)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare2/20/2014Anita CooperVPSell2,500$53.00$132,500.00View 2/18/2014Mark GoldbergCOOSell11,206$52.49$588,202.94View 2/12/2014Mark GoldbergCOOSell12,199$50.49$615,927.51View 2/11/2014Anita CooperVPSell10,000$50.00$500,000.00View 2/10/2014Eduard HoldenerDirectorSell6,000$49.62$297,720.00View 2/10/2014Rickenbach Josef VonCEOSell50,000$49.76$2,488,000.00View 2/7/2014Gadi SaaronyVPSell9,950$49.56$493,122.00View 2/7/2014Rickenbach Josef VonCEOSell50,000$49.70$2,485,000.00View 2/4/2014Christopher LindopDirectorSell10,000$49.00$490,000.00View 2/3/2014Douglas BattSVPSell8,000$48.58$388,640.00View 2/3/2014Mark GoldbergCOOSell13,529$48.70$658,862.30View 1/13/2014Mark GoldbergCOOSell6,957$48.90$340,197.30View 1/9/2014Mark GoldbergCOOSell6,901$46.49$320,827.49View 12/12/2013Xavier FlinoisInsiderBuy5,000$41.11$205,550.00View 9/11/2013Patrick FortuneDirectorSell7,000$48.31$338,170.00View 8/28/2013Richard LoveDirectorSell5,000$47.04$235,200.00View 6/4/2013Douglas A BattSVPSell15,000$45.15$677,250.00View 6/3/2013Mark A GoldbergCOOSell15,000$45.06$675,900.00View 5/20/2013Richard L LoveDirectorSell8,000$46.65$373,200.00View 5/14/2013A Dana Callow JrDirectorSell8,000$46.39$371,120.00View 5/13/2013Mark A GoldbergCOOSell28,887$45.19$1,305,403.53View 5/10/2013Anita CooperVPSell10,000$44.99$449,900.00View 5/9/2013Ulf I SchneiderSVPSell20,510$44.54$913,515.40View 10/4/2012Mark A GoldbergCOOSell5,000$32.00$160,000.00View (Data available from 1/1/2013 forward) About PAREXEL International Corp. PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company's product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance. In May 2013, PAREXEL International Corp acquired the entire share capital of HERON Group Ltd. Headlines: (2/21) Express Scripts Reports In-Line Earnings in Q4 (2/12) Charles River Beats Earnings Estimates in Q4 (2/21) Express Scripts Reports In-Line Earnings in Q4 - Analyst Blog Industry, Sector and Symbol: Sector: Healthcare Industry: Life Sciences Tools & Services Sub-Industry: Life Sciences Tools & Services Exchange: NASDAQ Symbol: PRXL CUSIP: 69946210 Key Metrics: Previous Close: $55.3250 Day Moving Average: $49.995200 Day Moving Average: $47.4632 P/E Ratio: 28.12P/E Growth: 1.27Market Cap: $3.130BCurrent Quarter EPS Consensus Estimate: $2.06 EPS Additional Links: View PRXL on Google FinanceView PRXL on Yahoo FinanceView PRXL's Company Profile on ReutersSearch for PAREXEL International Corp. on Google PAREXEL International Corp. (NASDAQ:PRXL) Chart for Friday, March, 7, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.